Lingaraj Nayak

COVID‐19 in cancer patients on active systemic therapy – Outcomes from LMIC scenario with an emphasis on need for active treatment

Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik et al. · Cancer Medicine · 2020 · 39 citations · Full text

ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country

Vanita Noronha, Anant Ramaswamy, Vijay Patil et al. · PLoS ONE · 2016 · 36 citations · Full text

Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol

Akhil Rajendra, Hasmukh Jain, V. N. Avinash Bonda et al. · Blood Advances · 2021 · 30 citations · Full text

A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)

Anshul Agarwal, Aakanksha Khandelwal, Kavita Pal et al. · PLoS ONE · 2022 · 24 citations · Full text

Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant

Anant Gokarn, Anup Toshniwal, Amogh Pathak et al. · Biology of Blood and Marrow Transplantation · 2019 · 23 citations